摘要
目的研究磁共振成像（MRI）在乳腺肿瘤穿刺定位与活检中的临床应用价值。方法选取2014年4月至2015年10月在本院接受MRI引导下穿刺定位或活检的乳腺肿瘤患者30例，回顾性统计所有患者的临床病理资料，分析其诊治情况以及随访结果。结果超声与钼靶无法诊断患者占比76．67％（23／30）；MRI检查显示恶性或疑似恶性患者21例，其中7例病理检查显示为良性，假阳性率为33．33％（7／21）；MRI检查显示为良性病变9例，其中1例病理检查为恶性，假阴性率为11．11％（1／9）。所有患者行MRI引导穿刺后均无血肿与感染发生。所有患者随访3～17个月，中位随访时间7．4个月。其中病死率为3．33％（1／30）、复发率为3．33％（1／30），其余患者复查均未见异常。结论MRI在乳腺肿瘤穿刺定位与活检中的临床应用价值较高，可显著提高乳腺肿瘤的诊治水平。
Objective To study the value of the clinical application of puncture positioning guided by magnetic resonance imaging （MRI）and biopsy for breast tumor. Methods 30 patients with breast tumor undertaking puncture positioning guided by MRI and biopsy at our hospital from April, 2014 to October, 2015 were selected. Their clinical and pathological data were retrospectively statistically analyzed. The diagnosis and treatment and follow-up results were analyzed. Results 76.67% （23/30）patients could not be diagnosed by ultrasonography and mammography. MRI showed that 21 patients had of were suspected malignant tumor; among the 21 cases, 7 cases confirmed with benign lesions by pathologic examination, with a false positive rate of 33.33% （7/21）. MRI showed that 9 cases had benign lesions, but 1 case were confirmed with malignant lesions by pathological examination, with a false negative rate of 11.11% （1/9）. No case got hematoma and infection after puncture guided by MRI. All the patients were followed up for 3 - 17 months and the median follow-up time was 7.4 months.The mortality was 3.33% （1/30）. The recurrence rate was 3.33% （1/30） and the rest patients were found no abnormal situation by rechecking. Conclusion The value of MRI in the localization and biopsy of breast tumor is high and can significantly improve the diagnosis and treatment of breast tumor.
出处
《国际医药卫生导报》
2018年第4期517-519,共3页
International Medicine and Health Guidance News
